Apr 15, 2025
105:104
For every 104 shares held, investors received 105. The price per share adjusted from $0.14 to $0.14.
The split itself did not change the total investment value.
Recce Pharmaceuticals Ltd. (GETTEX:R9Q) operates in the Pharmaceuticals: major industry.
Recce Pharmaceuticals Ltd. company overviewRecce Pharmaceuticals Ltd.'s most recent stock split was on April 15, 2025. It was a 105-for-104 forward split, so shareholders received 105 shares for every 104 they held.
Recce Pharmaceuticals Ltd. (GETTEX:R9Q) has split its stock 2 times: a 405-for-401 split on September 13, 2023 and a 105-for-104 split on April 15, 2025.
Recce Pharmaceuticals Ltd. has split its stock 2 times. This history records 2 forward splits between September 13, 2023 and April 15, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Recce Pharmaceuticals Ltd.'s 105-for-104 split on April 15, 2025, every 104 shares became 105 shares.
Recce Pharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on April 15, 2025, 1 year ago. Companies announce splits in advance, and any new GETTEX:R9Q split will appear on this page.
Already premium?